| Theme | SGLT2 Inhibitors: A Game Changer for Diabetes and Beyond? |
| Date & Time | 21st Nov Friday 14:15 - 14:55 Hrs |
| Location | Hall- B |
| Role | Chairperson |
| Topic | Debate : SGLT2i are the anti-diabetic medications of choice for MASLD without morbid obesity PPAR agonists in MASLD – Does it still have a role in GLP1 analouge era? |